Spyre Therapeutics
SYRE
#5743
Rank
NZ$1.42 B
Marketcap
$23.69
Share price
-5.36%
Change (1 day)
-56.52%
Change (1 year)

Earnings for Spyre Therapeutics (SYRE)

Earnings in 2024 (TTM): -NZ$0.35 Billion

According to Spyre Therapeutics's latest financial reports the company's current earnings are N/A. a decrease over its 2023 earnings that were of -NZ$0.22 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Spyre Therapeutics from 2014 to 2024

Annual earnings

Year Earnings Change
2024 -NZ$0.35 Billion62.23%
2023 -NZ$0.22 Billion51.64%
2022 -NZ$0.15 Billion29.14%
2021 -NZ$0.12 Billion-19.43%
2020 -NZ$0.14 Billion1.43%
2019 -NZ$0.14 Billion76.7%
2018 -NZ$76.24 Million64.27%
2017 -NZ$46.41 Million26.34%
2016 -NZ$36.74 Million93.6%
2015 -NZ$18.98 Million27.08%
2014 -NZ$14.94 Million